Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsu Hayashida

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
BMC Cancer|June 30, 2018
Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trialTetsu Hayashida, Hiromitsu Jinno, Katsuaki Mori, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
Polysulfide Serves as a Hallmark of Desmoplastic Reaction to Differentially Diagnose Ductal Carcinoma In Situ and Invasive Breast Cancer by SERS ImagingAkiko Kubo, Yohei Masugi, Takeshi Hase, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasisTetsu Hayashida, Fumiyuki Takahashi, Naokazu Chiba, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
Homeobox B9 induces epithelial-to-mesenchymal transition-associated radioresistance by accelerating DNA damage responsesNaokazu Chiba, Valentine Comaills, Bunsyo Shiotani, et al.
Heart and Vessels|December 30, 2025
Global longitudinal strain decline after anthracyclines in a relatively low-risk Japanese breast cancer cohortKyohei Daigo, Yasuyuki Shiraishi, Seien Ko, et al.
Cancer Science|June 15, 2021
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNAKuniko Sunami, Hideaki Bando, Yasushi Yatabe, et al.
Medical Oncology (Northwood, London, England)|March 12, 2021
Estimating copy number using next-generation sequencing to determine ERBB2 amplification statusKohei Nakamura, Eriko Aimono, Junna Oba, et al.
Scientific Reports|May 30, 2019
Establishment of a model of sentinel lymph node metastasis using immunodeficient swineToshiaki Kurihara, Sachiko Matsuda, Yuki Nakamura, et al.
Breast Cancer (Tokyo, Japan)|May 13, 2026
Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancerMiharu Kano, Kanae Taruno, Mayuko Inuzuka, et al.
Breast Cancer Research and Treatment|December 9, 2022
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancerAkihiko Shimomura, Masayuki Yoshida, Takashi Kubo, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
BMC Cancer|June 30, 2018
Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trialTetsu Hayashida, Hiromitsu Jinno, Katsuaki Mori, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
Polysulfide Serves as a Hallmark of Desmoplastic Reaction to Differentially Diagnose Ductal Carcinoma In Situ and Invasive Breast Cancer by SERS ImagingAkiko Kubo, Yohei Masugi, Takeshi Hase, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasisTetsu Hayashida, Fumiyuki Takahashi, Naokazu Chiba, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
Homeobox B9 induces epithelial-to-mesenchymal transition-associated radioresistance by accelerating DNA damage responsesNaokazu Chiba, Valentine Comaills, Bunsyo Shiotani, et al.
Heart and Vessels|December 30, 2025
Global longitudinal strain decline after anthracyclines in a relatively low-risk Japanese breast cancer cohortKyohei Daigo, Yasuyuki Shiraishi, Seien Ko, et al.
Cancer Science|June 15, 2021
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNAKuniko Sunami, Hideaki Bando, Yasushi Yatabe, et al.
Medical Oncology (Northwood, London, England)|March 12, 2021
Estimating copy number using next-generation sequencing to determine ERBB2 amplification statusKohei Nakamura, Eriko Aimono, Junna Oba, et al.
Scientific Reports|May 30, 2019
Establishment of a model of sentinel lymph node metastasis using immunodeficient swineToshiaki Kurihara, Sachiko Matsuda, Yuki Nakamura, et al.
Breast Cancer (Tokyo, Japan)|May 13, 2026
Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancerMiharu Kano, Kanae Taruno, Mayuko Inuzuka, et al.
Breast Cancer Research and Treatment|December 9, 2022
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancerAkihiko Shimomura, Masayuki Yoshida, Takashi Kubo, et al.
Pageof 9